New Drug Approved for Early Alzheimer’s - The New York Times
WEBJul 2, 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and...
Dementia News - ScienceDaily
WEB3 days ago · Read the latest medical research on dementia. Causes, symptoms, lowering the risks, care, medications and new treatments for dementia.
House Approves Bipartisan Legislation to Strengthen Dementia …
WEB2 days ago · Washington, D.C., September 17, 2024 — Today the U.S. House of Representatives unanimously passed the bipartisan BOLD Infrastructure for Alzheimer’s Reauthorization Act (H.R. 7218 / S. 3775), legislation championed by the Alzheimer's Association and the Alzheimer's Impact Movement (AIM).
FDA approves new Alzheimer’s drug that appears to slow disease - NBC News
WEBJan 6, 2023 · Alzheimer’s is the seventh-leading cause of death in the U.S., according to the Centers for Disease Control and Prevention. Most drugs approved by the FDA for Alzheimer’s are aimed at helping...
Lifestyle changes may slow or improve Alzheimer’s and dementia ... - CNN
WEBJun 7, 2024 · Ten people saw their cognition actually improve, while a blood test found levels of amyloid, a hallmark of Alzheimer’s disease, were retreating, said lead study author Dr. Dean Ornish, a ...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
WEBJul 6, 2023 · Andrew Harnik/AP. The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should...
New research finds higher levels of leptin indicate brain protection ...
WEB9 hours ago · New research is more closely linking obesity to dementia. Higher levels of leptin, a hormone that helps maintain normal body weight, is associated with better signal-transmitting brain white ...
Start of new era for Alzheimer’s treatment — Harvard Gazette
WEBJun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease. The drug, lecanemab, is a monoclonal antibody that works by binding to a key protein linked to the malady ...
HHS Releases National Plan Update Marking Year of Progress on …
WEBDec 12, 2023 · The National Plan is a roadmap of strategies and actions of how HHS and its partners can accelerate research, expand treatments, improve care, support people living with dementia and their caregivers, and encourage action to reduce risk factors.
News | Alzheimer's Association
WEBAug 22, 2024 · News updates for Alzheimer's and related dementias – find the latest information on treatments, care, research and Alzheimer's Association events.